A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)
Clinical trial NCT06470763 · COMPLETED
Trial details
- NCT number
- NCT06470763
- Sponsor
- Anaveon AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-06-22
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.